- Home
- GDTC vs CDIO Comparison
GDTC vs CDIO Comparison
Compare GDTC & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- CDIO
- Stock Information
- Founded
- GDTC 2018
- CDIO 2017
- Country
- GDTC Singapore
- CDIO United States
- Employees
- GDTC N/A
- CDIO N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GDTC Health Care
- CDIO Health Care
- Exchange
- GDTC Nasdaq
- CDIO Nasdaq
- Market Cap
- GDTC 29.4M
- CDIO 23.6M
- IPO Year
- GDTC 2023
- CDIO N/A
- Fundamental
- Price
- GDTC $2.23
- CDIO $0.34
- Analyst Decision
- GDTC Buy
- CDIO Buy
- Analyst Count
- GDTC 1
- CDIO 1
- Target Price
- GDTC $5.00
- CDIO $2.00
- AVG Volume (30 Days)
- GDTC 15.9K
- CDIO 807.0K
- Earning Date
- GDTC 01-01-0001
- CDIO 05-14-2025
- Dividend Yield
- GDTC N/A
- CDIO N/A
- EPS Growth
- GDTC N/A
- CDIO N/A
- EPS
- GDTC N/A
- CDIO N/A
- Revenue
- GDTC $330,254.00
- CDIO $34,890.00
- Revenue This Year
- GDTC $14.71
- CDIO $1,434.82
- Revenue Next Year
- GDTC N/A
- CDIO $4,661.91
- P/E Ratio
- GDTC N/A
- CDIO N/A
- Revenue Growth
- GDTC N/A
- CDIO 104.45
- 52 Week Low
- GDTC $1.20
- CDIO $0.19
- 52 Week High
- GDTC $4.05
- CDIO $1.77
- Technical
- Relative Strength Index (RSI)
- GDTC 34.89
- CDIO 36.17
- Support Level
- GDTC $1.98
- CDIO $0.30
- Resistance Level
- GDTC $2.56
- CDIO $0.40
- Average True Range (ATR)
- GDTC 0.18
- CDIO 0.05
- MACD
- GDTC -0.04
- CDIO -0.01
- Stochastic Oscillator
- GDTC 31.25
- CDIO 25.95
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.